Clotibrate improves glucose tolerance in fat-fed rats but decreases hepatic glucose consumption capacity

Journal of Hepatology

Volumn 37, Issue 4, 2002, Pages 425-431

  Gustafson, Lori A ^a   Kuipers, Folkert ^b   Wiegman, Coen ^b   Sauerwein, Hans P ^c   Romijn, Johannes A ^d   Meijer, Alfred J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Department of Pediatrics   (Netherlands)

^c Metabolism Unit   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clofibrate; Glucose; Glycogen; High fat diet; Insulin

Indexed keywords

ACYL COENZYME A OXIDASE; CLOFIBRATE; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; INSULIN; LONG CHAIN FATTY ACID; PYRUVATE KINASE; ANTILIPEMIC AGENT; CELL RECEPTOR; FATTY ACID; GLUCAGON; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL METABOLIC RATE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID OXIDATION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TOLERANCE; GLYCOGEN LIVER LEVEL; GLYCOGEN METABOLISM; GLYCOLYSIS; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID DIET; LIVER METABOLISM; LIVER MITOCHONDRION; MALE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; WEIGHT GAIN; ANIMAL; ANIMAL FOOD; BLOOD; DRUG EFFECT; DRUG POTENTIATION; EATING; FAT INTAKE; GLUCOSE BLOOD LEVEL; LIVER; METABOLISM; WISTAR RAT;

ANIMAL FEED; ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; BODY TEMPERATURE; CLOFIBRATE; DIETARY FATS; EATING; FATTY ACIDS, NONESTERIFIED; GLUCAGON; GLUCOKINASE; GLUCOSE INTOLERANCE; GLUCOSE-6-PHOSPHATASE; GLYCOGEN; INSULIN; LIVER; MALE; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; WEIGHT GAIN;

EID: 0036784130     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00212-X     Document Type: Article

References (48)

1. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
2. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and DM2. Diabetes 1997;46:3-10.
3. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-481.
4. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 1992;258:766-770.
5. Tappy L, Acheson K. Role of substrate competition in the pathogenesis of insulin resistance in man. Eur J Endocrinol 1998;138:10-15.
6. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;i:785-789.
7. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088-2093.
8. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-1245.
9. Goldberg R, La Belle P, Zupkis R, Ronca P. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in noninsulin-dependent diabetes mellitus. Am J Cardiol 1990;66:16B-21B.
10. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-650.
11. Everett L, Galli A, Crabb D. The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. Liver 2000;20:191-199.
12. Lazarow PB. Three hypolipidemic drugs increase hepatic palmitoylcoenzyme A oxidation in the rat. Science 1977;197:580-581.
13. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J Biol Chem 1997;272:28210-28217.
14. Kobayashi M, Shigeta Y, Hirata Y, Omori Y, Sakamoto N, Nambu S, et al. Improvement of glucose tolerance in NIDDM by clofibrate: randomized double-blind study. Diabetes Care 1988;11:495-499.
15. Jones IR, Swai A, Taylor R, Miller M, Laker MF, Alberti KGMM. Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM. Diabetes Care 1990;13:855-863.
16. Guerre-Millo M, Gervois P, Raspe E, Madsen L, Poulain P, Derudas B, et al. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and adiposity. J Biol Chem 2000;275: 16638-16642.
17. Bergmeyer HU. Methods of enzymatic analysis. 2nd ed. New York, NY: Academic Press, 1974.
18. Lavoinne A, Baquet A, Hue L. Stimulation of glycogen synthesis and lipogenesis by glutamine in isolated rat hepatocytes. Biochem J 1987;248:429-437.
19. Hue L, Bontemps F, Hers HG. The effects of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations. Biochem J 1975;152:105-114.
20. Uhing RJ, Janski AM, Graves DJ. The effect of solvents on nucleotide regulation of glycogen phosphorylase. J Biol Chem 1979;254:3166-3169.
21. Bisschop PH, Pereira Arias AM, Ackermans MT, Endert E, Pijl H, Kuipers F, et al. The effects of carbohydrate variation in isocaloric diets on glycogenolysis and gluconeogenesis in healthy men. J Clin Endocrinol Metab 2000;85:1963-1967.
22. Davidson AL, Arion WJ. Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch Biochem Biophys 1987;253:156-167.
23. Vamecq J. Fluorometric assay of peroxisomal oxidases. Anal Biochem 1990;186:340-349.
24. Wanders RJ, Van Roermund CW, Meijer AJ. Analysis of the control of citrulline synthesis in isolated rat-liver mitochondria. Eur J Biochem 1984;142:247-254.
25. Lowry OH, Roseborough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
26. Benthem L, Keizer K, Wiegman CH, de Boer SF, Strubbe JH, Steffens AB, et al. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol Endocrinol Metab 2000;279:E1286-1293.
27. Conover WJ. Practical non-parametric statistics. 2nd ed. New York, NY: Wiley, 1980 229-237.
28. Cai Y, Nelson BD, Li R, Luciakova K, dePierre JW. Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis. Arch Biochem Biophys 1996;325:107-112.
29. Shin M, Iwamoto N, Yamashita M, Sano K, Umezawa C. Pyridine nucleotide levels in liver of rats fed clofibrate- or pyrazinamide-containing diets. Biochem Pharmacol 1998;55:367-371.
30. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-2446.
31. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97:2859-2865.
32. Matsui H, Okumura K, Kawakami K, Hibino M, Toki Y, Ito T. Improved insulin sensitivity by bezafibrate in rats. Relationship to fatty acid composition of skeletal-muscle triglycerides. Diabetes 1997;46:348-353.
33. Mithieux G. New knowledge regarding glucose-6 phosphatase gene and protein and their roles in the regulation of glucose metabolism. Eur J Endocrinol 1997;136:137-145.
34. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Ann Rev Nutr 1999;19:379-406.
35. Henly DC, Phillips JW, Berry MN. Suppression of glycolysis is associated with an increase in glucose cycling in hepatocytes form diabetic rats. J Biol Chem 1996;271:11268-11271.
36. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 1997;46:1768-1774.
37. Minassian C, Tarpin S, Mithieux G. Role of glucose-6 phosphatase, glucokinase, and glucose-6 phosphate in liver insulin resistance and its correction by metformin. Biochem Pharmacol 1998;55:1213-1219.
38. Girard J, Ferré P, Foufelle F. Mechanism by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Ann Rev Nutr 1997;17:325-352.
39. Aiston S, Trinh KY, Lange AJ, Newgard CB, Agius L. Glucose-6-phosphatase overexpression lowers glucose 6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation. Evidence against feedback inhibition of glucokinase. J Biol Chem 1999;274:24559-24566.
40. van Dijk TH, van der Sluijs FH, Wiegman CH, Baller JF, Gustafson LA, Burger HJ, et al. Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048. J Biol Chem 2001;276:25727-25735.
41. Aiston S, Peak M, Agius L. Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats: the role of increased phosphorylase activity. Diabetologia 2000;43:589-597.
42. Henly DC, Chauvet MC, Phillips JW. Hepatic glucose cycling does not contribute to the development of hyperglycemia in Zucker diabetic fatty rats. Diabetes 1999;48:342-346.
43. Green S. PPAR: a mediator of peroxisome proliferator action. Mutat Res 1995;333:101-109.
44. Hertz R, Aurbach R, Hashimoto T, Bar-Tana J. Thyromimetic effect of peroxisomal proliferators in rat liver. Biochem J 1991;274:745-751.
45. Kersten S. Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999;103:1489-1498.
46. Mancini FP, Lanni A, Sabatino L, Moreno M, Giannino A, Contaldo F, et al. FEBS Lett 2001;491:154-158.
47. Brun S, Carmona MC, Mampel T, Vinas O, Giralt M, Iglesias R, et al. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 1999;48: 1217-1222.
48. Li B, Nolte LA, Ju JS, Ho Han D, Coleman T, Holloszy JO, et al. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat Med 2000;6:1115-1120.